Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subhash C Sinha

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
The Journal of Organic Chemistry|January 24, 1997
Total Synthesis of (+)-Aspicilin. The Naked Carbon Skeleton Strategy vs the Bioorganic ApproachSubhash C. Sinha, Ehud Keinan
Tetrahedron Letters|February 18, 2010
Studies toward the duocarmycin prodrugs for the antibody prodrug therapy approachLian-Sheng Li, Subhash C Sinha
The Journal of Organic Chemistry|October 24, 2001
Total Synthesis of UvaricinAhmad Yazbak, Subhash C. Sinha, Ehud Keinan
Organic Letters|May 17, 2007
Studies toward the total synthesis of sorangiolides and their analogues. A convergent stereoselective synthesis of the macrocyclic lactone precursorsSanjib Das, Sunny Abraham, Subhash C Sinha
Organic Letters|January 3, 2004
Efficient one-step aldol-type reaction of ketones with acetals and ketals mediated by dibutylboron triflate/diisopropylethyl amineLian-Sheng Li, Sanjib Das, Subhash C Sinha
Organic Letters|January 3, 2004
Stereoselective aldol-type cyclization reaction mediated by dibutylboron triflate/diisopropylethylamineSanjib Das, Lian-Sheng Li, Subhash C Sinha
The Journal of Clinical Investigation|June 1, 2026
Expanding roles of cGAS-STING signaling in neuroinflammationWeixi Feng, Abulimiti Aikedan, Subhash C Sinha, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2009
Instant immunity through chemically programmable vaccination and covalent self-assemblyMikhail Popkov, Beatriz Gonzalez, Subhash C Sinha, et al.
Molecular Pharmaceutics|May 31, 2015
Chemically Programmed Bispecific Antibody Targeting Legumain Protease and αvβ3 Integrin Mediates Strong Antitumor EffectsYuan Liu, Rajib K Goswami, Cheng Liu, et al.
Molecular Pharmaceutics|November 3, 2011
Targeting cell surface alpha(v)beta(3) integrin increases therapeutic efficacies of a legumain protease-activated auristatin prodrugYuan Liu, Krishna Mohan Bajjuri, Cheng Liu, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
The Journal of Organic Chemistry|January 24, 1997
Total Synthesis of (+)-Aspicilin. The Naked Carbon Skeleton Strategy vs the Bioorganic ApproachSubhash C. Sinha, Ehud Keinan
Tetrahedron Letters|February 18, 2010
Studies toward the duocarmycin prodrugs for the antibody prodrug therapy approachLian-Sheng Li, Subhash C Sinha
The Journal of Organic Chemistry|October 24, 2001
Total Synthesis of UvaricinAhmad Yazbak, Subhash C. Sinha, Ehud Keinan
Organic Letters|May 17, 2007
Studies toward the total synthesis of sorangiolides and their analogues. A convergent stereoselective synthesis of the macrocyclic lactone precursorsSanjib Das, Sunny Abraham, Subhash C Sinha
Organic Letters|January 3, 2004
Efficient one-step aldol-type reaction of ketones with acetals and ketals mediated by dibutylboron triflate/diisopropylethyl amineLian-Sheng Li, Sanjib Das, Subhash C Sinha
Organic Letters|January 3, 2004
Stereoselective aldol-type cyclization reaction mediated by dibutylboron triflate/diisopropylethylamineSanjib Das, Lian-Sheng Li, Subhash C Sinha
The Journal of Clinical Investigation|June 1, 2026
Expanding roles of cGAS-STING signaling in neuroinflammationWeixi Feng, Abulimiti Aikedan, Subhash C Sinha, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2009
Instant immunity through chemically programmable vaccination and covalent self-assemblyMikhail Popkov, Beatriz Gonzalez, Subhash C Sinha, et al.
Molecular Pharmaceutics|May 31, 2015
Chemically Programmed Bispecific Antibody Targeting Legumain Protease and αvβ3 Integrin Mediates Strong Antitumor EffectsYuan Liu, Rajib K Goswami, Cheng Liu, et al.
Molecular Pharmaceutics|November 3, 2011
Targeting cell surface alpha(v)beta(3) integrin increases therapeutic efficacies of a legumain protease-activated auristatin prodrugYuan Liu, Krishna Mohan Bajjuri, Cheng Liu, et al.
Pageof 7